intraaort
balloon
pump
iabp
wide
use
hemodynam
support
critic
patient
cardiogen
shock
cs
examin
whether
inhospit
mortal
patient
taiwan
treat
iabp
recent
declin
use
taiwan
nation
health
insur
research
databas
retrospect
review
inhospit
allcaus
mortal
men
older
patient
treat
iabp
mortal
rate
n
urban
level
hospit
number
day
intens
care
unit
hospit
iabp
treatment
prior
percutan
coronari
intervent
pci
associ
mortal
seven
thousand
six
hundr
thirtyf
patient
underw
coronari
arteri
bypass
graft
cabg
surgeri
underw
highrisk
pci
iabp
treatment
number
patient
treat
iabp
significantli
increas
decad
p
trend
inhospit
allcaus
mortal
patient
treat
iabp
significantli
decreas
p
trend
inhospit
allcaus
mortal
patient
underw
cabg
pci
plu
iabp
decreas
conclus
inhospit
mortal
rate
iabp
treatment
decreas
annual
taiwan
studi
period
howev
highrisk
patient
underw
coronari
revascular
iabp
higher
unstabl
inhospit
mortal
rate
intraaort
balloon
pump
iabp
wide
use
circulatori
assist
method
patient
cardiogen
shock
cs
increas
myocardi
peripher
perfus
reduc
afterload
improv
cardiac
output
also
use
patient
wean
cardiopulmonari
bypass
cpb
recent
metaanalysi
report
preoper
mortal
significantli
lower
patient
underw
coronari
arteri
bypass
graft
cabg
plu
periop
iabp
iabp
sometim
use
ventricular
arrhythmia
highrisk
percutan
coronari
intervent
pci
use
iabp
thrombolyt
therapi
increas
surviv
rate
patient
acut
myocardi
infarct
ami
cs
thu
iabp
intervent
might
reduc
periop
mortal
howev
iabpshock
ii
trial
outcom
followedup
year
show
reduct
mortal
patient
ami
cs
also
underw
earli
pci
treatment
guidelin
stsegment
myocardi
infarct
stemi
cs
iabp
iib
indic
europ
iia
indic
usa
benchmark
registri
data
show
inhospit
mortal
patient
treat
iabp
recent
studi
usa
databas
said
patient
treat
iabp
pci
tempor
reduct
allcaus
mortal
howev
unknown
whether
recent
declin
inhospit
mortal
critic
patient
treat
iabp
examin
trend
inhospit
allcaus
mortal
critic
patient
treat
iabp
survey
major
diseas
patient
treat
iabp
inform
consent
origin
obtain
nation
health
research
institut
taiwan
avoid
potenti
ethic
violat
relat
data
privaci
individu
inform
protect
deidentifi
data
thu
inform
consent
requir
exempt
obtain
institut
review
board
chi
mei
medic
center
irb
use
taiwan
nation
health
insur
research
databas
nhird
nationwid
studi
patient
treat
iabp
nhird
consist
detail
healthcar
claim
data
million
enrolle
taiwan
popul
detail
nhird
describ
hundr
publish
paper
retrospect
populationbas
studi
inpati
expenditur
hospit
admiss
examin
determin
inhospit
mortal
patient
treat
iabp
identifi
hospit
patient
treat
iabp
first
two
intern
classif
diseas
ninth
revis
clinic
modif
diagnosi
code
code
also
use
identifi
patient
treat
iabp
underw
pci
cabg
identifi
patient
treat
iabp
baselin
comorbid
hypertens
htn
diabet
mellitu
dm
hyperlipidemia
myocardi
infarct
mi
cerebrovascular
attack
cva
comorbid
select
base
frequenc
appear
age
gender
urban
level
hospit
level
number
day
intens
care
unit
icu
length
hospit
durat
iabp
treatment
also
analyz
level
urban
taiwan
township
base
taiwanes
paper
includ
index
variabl
popul
densiti
ratio
educ
level
peopl
colleg
educ
ratio
elderli
year
peopl
ratio
peopl
employ
agricultur
worker
number
physician
per
peopl
inhospit
mortal
defin
number
patient
treat
iabp
die
discharg
hospit
categor
variabl
present
frequenc
percentag
compar
use
pearson
test
continu
variabl
present
mean
standard
deviat
sd
median
interquartil
rang
compar
use
student
test
wilcoxon
ranksum
test
cochranarmitag
trend
test
use
categor
data
analysi
test
associ
trend
proport
specif
period
cumul
mortal
first
day
patient
hospit
stay
character
use
kaplanmei
plot
logrank
test
use
comparison
gender
differ
age
group
sa
sa
institut
cari
nc
use
statist
analys
kaplanmei
curv
plot
use
stata
stata
corp
colleg
station
tx
signific
set
p
twotail
urban
level
length
hospit
stay
length
icu
stay
posit
associ
mortal
whether
patient
treat
medic
center
effect
inhospit
mortal
rate
mean
durat
iabp
treatment
day
patient
die
hospit
treat
iabp
longer
time
p
tabl
baselin
clinic
histori
patient
treat
iabp
show
htn
n
dm
n
prior
mi
n
prior
cva
n
prior
heart
failur
n
prior
cabg
n
surgeri
prior
pci
n
tabl
moreov
histori
pci
show
signific
p
differ
inhospit
mortal
surviv
iabp
use
taiwan
increas
annual
sinc
inhospit
mortal
rate
per
iabp
decreas
annual
sinc
except
spike
sever
acut
respiratori
syndrom
sar
fig
annual
inhospit
mortal
rate
patient
treat
iabp
particular
year
fell
two
inhospit
mortal
trend
fig
one
patient
underw
cabg
iabp
p
trend
particular
year
one
patient
underw
pci
iabp
p
trend
particular
year
addit
inhospit
mortal
patient
treat
iabp
differ
significantli
gender
month
logrank
test
p
fig
howev
patient
year
surviv
mean
month
longer
age
group
logrank
test
p
fig
inhospit
mortal
patient
ami
cs
tabl
patient
ami
cs
treat
iabp
retrospect
divid
three
group
iabponli
pciiabp
cabgiabp
inhospit
mortal
rate
significantli
differ
three
group
iabponli
cabgiabp
pciiabp
inhospit
mortal
patient
treat
cabg
iabp
admiss
patient
treat
cabg
iabp
vessel
admiss
higher
inhospit
mortal
rate
mortal
patient
treat
iabp
pci
vessel
vessel
vessel
admiss
significantli
differ
inhospit
mortal
patient
treat
pcionli
plu
iabp
base
first
two
discharg
diagnosi
code
six
major
comorbid
diseas
hospit
patient
treat
iabp
identifi
acut
coronari
syndrom
ac
largepopul
cohort
studi
found
inhospit
mortal
per
given
iabp
treatment
fallen
annual
taiwan
despit
annual
increas
number
patient
treat
iabp
howev
inhospit
mortal
higher
patient
treat
coronari
revascular
plu
iabp
contrari
overal
trend
patient
treat
iabp
period
men
women
studi
treat
iabp
consist
studi
inhospit
allcaus
mortal
patient
treat
iabp
significantli
lower
america
europ
lower
inhospit
mortal
studi
might
attribut
improv
medic
care
given
patient
taiwan
medic
use
differ
condit
use
iabp
year
also
found
shorter
hospit
longer
durat
iabp
use
associ
higher
mortal
hospitallevelbas
differ
inhospit
mortal
rate
patient
treat
iabp
studi
consist
nation
cardiovascular
data
registri
studi
benchmark
registri
studi
women
greater
risk
major
complic
iabp
patient
year
old
treat
iabp
highest
inhospit
mortal
rate
inhospit
mortal
patient
year
old
treat
iabp
second
highest
mortal
rate
lowest
age
group
probabl
patient
year
old
fewer
comorbid
diseas
consensu
time
remov
intraaort
balloon
pump
bignami
et
al
indic
intraaort
balloon
pump
remov
first
two
day
studi
averag
durat
iabp
treatment
day
durat
patient
die
hospit
significantli
longer
patient
surviv
vs
day
respect
p
find
confirm
claim
time
remov
intraaort
balloon
pump
depend
upon
medic
condit
patient
protocol
hospit
addit
offer
new
inform
differ
area
iabp
manag
time
iabp
remov
chen
et
al
report
higher
risk
mortal
peopl
ischem
heart
diseas
less
urban
area
taiwan
anoth
studi
show
higher
mortal
coronari
heart
diseas
rural
area
unit
state
also
investig
associ
urban
inhospit
mortal
patient
treat
iabp
found
less
urban
area
taiwan
patient
treat
iabp
higher
inhospit
mortal
probabl
fewer
healthcar
resourc
access
healthcar
resourc
rapid
easi
urban
area
present
studi
discharg
diagnosi
code
show
iabp
frequent
use
patient
cad
patient
n
treat
iabp
cabg
admiss
therefor
assum
patient
requir
iabp
wean
cpb
treat
cs
benchmark
registri
data
show
iabp
often
use
provid
hemodynam
support
cardiac
catheter
studi
show
inhospit
allcaus
mortal
rate
patient
treat
cabgiabp
hospit
similar
mortal
rate
report
hemo
et
al
higher
inhospit
mortal
rate
benchmark
registri
addit
suggest
higher
risk
inhospit
mortal
pci
combin
iabp
rate
patient
anoth
recent
larg
nationwid
studi
report
inhospit
mortal
patient
usa
treat
pci
plu
iabp
declin
earli
benchmark
registri
data
report
inhospit
mortal
rate
patient
underw
pci
combin
iabp
recent
balloon
pumpassist
coronari
intervent
studi
report
rate
major
advers
cardiac
cardiovascular
event
patient
undergo
highrisk
pci
combin
iabp
inhospit
mortal
rate
patient
cs
treat
iabp
incid
rate
ami
comorbid
cs
patient
ac
inhospit
mortal
rate
patient
ami
comorbid
cs
much
lower
studi
babaev
et
al
report
inhospit
mortal
rate
patient
ami
comorbid
cs
list
nation
registri
myocardi
infarct
nrmi
patient
underw
primari
pci
patient
underw
cabg
benchmark
registri
databas
inhospit
mortal
patient
cs
treat
iabp
think
two
possibl
reason
lower
mortal
rate
patient
ami
comorbid
cs
studi
firstli
emerg
revascular
use
pci
cabg
done
taiwan
patient
stemi
comorbid
cs
base
current
american
colleg
cardiolog
foundationamerican
heart
associ
accfaha
guidelin
customari
daili
practic
patient
ami
cs
treat
iabp
studi
undergon
cabg
undergon
pci
treat
medic
therefor
patient
ami
comorbid
cs
treat
iabp
underw
cabg
inhospit
mortal
rate
hemo
et
al
report
inhospit
mortal
rate
patient
cs
undergo
cabg
sp
iabp
secondli
ami
comorbid
cs
studi
consid
major
diseas
exclud
patient
ami
cs
major
diagnosi
patient
higher
inhospit
mortal
rate
comorbid
studi
limit
first
retrospect
analysi
base
data
health
insur
claim
databas
diagnos
base
code
patient
medic
chart
person
observ
author
nhird
provid
detail
hemodynam
data
patholog
data
rate
diseas
sever
iabprel
complic
vascular
septic
complic
caus
death
infer
claim
record
addit
studi
focu
ami
cs
major
diagnosi
base
first
two
code
discharg
diagnos
patient
ami
includ
studi
cs
one
first
two
code
thu
exclud
possibl
unmeasur
factor
may
confound
result
second
could
obtain
patient
medic
chart
know
precis
patient
treat
iabp
howev
use
first
two
code
detect
patient
main
diseas
confid
like
reason
iabp
treatment
third
unabl
determin
whether
pci
cabg
iabp
treatment
cardiac
catheter
inhospit
mortal
rate
iabp
treatment
decreas
annual
taiwan
trend
inhospit
mortal
patient
underw
coronari
revascular
present
similar
trend
highrisk
patient
underw
coronari
revascular
iabp
higher
unstabl
inhospit
mortal
rate
studi
offer
valuabl
inform
mortal
use
iabp
taiwan
